Trends and exceptions of physical 357 properties on antibacterial activity for Gram-positive and Gram-negative pathogens, J, vol.358 ,
, Med Chem, vol.57, pp.10144-61, 2014.
Drugs for bad bugs: confronting the challenges of 360 antibacterial discovery, Nat Rev Drug Discov, vol.6, pp.29-40, 2007. ,
Overview: Global and local impact of antibiotic resistance ,
, Antibiot Resist Chall Oppor, vol.30, pp.313-335, 2016.
Access to effective antimicrobials: a worldwide 364 challenge, The Lancet, vol.387, pp.168-75, 2016. ,
10 x '20 Progress--development of new 366 drugs active against gram-negative bacilli: an update from the, Infectious Diseases, vol.367 ,
, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.56, pp.1685-94, 2013.
Discovery and development of new antibacterial agents targeting Gram-369 negative bacteria in the era of pandrug resistance: is the future promising?, Curr Opin 370 Pharmacol, vol.18, pp.91-98, 2014. ,
Molecular basis of bacterial outer membrane permeability revisited ,
, Mol Biol Rev, vol.67, pp.593-656, 2003.
The porin and the permeating antibiotic: a selective 374 diffusion barrier in Gram-negative bacteria, Nat Rev Microbiol, vol.6, pp.893-903, 2008. ,
Molecular mechanisms of antibiotic resistance ,
, Nat Rev Microbiol, vol.13, pp.42-51, 2015.
Prevention of drug access to bacterial targets: permeability barriers and active 380 efflux. -Semantic Scholar, Nat Microbiol, vol.2, pp.593-656, 1994. ,
The challenge of efflux-mediated antibiotic resistance in 382 ,
, Gram-negative bacteria, Clin Microbiol Rev, vol.28, pp.337-418, 2015.
Membrane permeability and regulation of 384 drug 'influx and efflux' in Enterobacterial pathogens, Curr Drug Targets, vol.9, pp.750-385, 2008. ,
Permeability barrier of Gram-negative cell 387 envelopes and approaches to bypass it, ACS Infect Dis, vol.1, pp.512-534, 2015. ,
Synergy between active efflux and outer 389 membrane diffusion defines rules of antibiotic permeation into Gram-negative bacteria, 390 mBio, vol.8, pp.1172-1189, 2017. ,
Strategies for bypassing the membrane 392 barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011. ,
How to get good drugs into 394 bad bugs, Sci Transl Med, vol.6, pp.228-235, 2014. ,
How to measure export via bacterial multidrug resistance efflux 396 pumps, mBio, 2016. ,
, Data normality was checked by the Shapiro-Wilk test and 521 homogeneity of variances was checked by the Fligner-Killeen test